Abeona Therapeutics Inc. (ABEO) Financial Statements (2024 and earlier)

Company Profile

Business Address 6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:52,50050,90095,000129,25885,000137,750
Cash and cash equivalents14,21732,93812,596129,25818,750137,750
Short-term investments37,93212,08682,438 66,218 
Other undisclosed cash, cash equivalents, and short-term investments3515,876(34) 32 
Receivables1883,000  81107
Other undisclosed current assets4111,5012,7423,1323,7702,735
Total current assets:53,09955,40197,742132,39088,851140,592
Noncurrent Assets
Operating lease, right-of-use asset5,3319,4037,0328,047
Property, plant and equipment5,74112,33911,32213,1579,4431,374
Intangible assets, net (including goodwill) 1,3551,38433,96668,64475,50836,443
Goodwill   32,46632,46632,46632,466
Intangible assets, net (excluding goodwill) 1,3551,3841,50036,17843,0423,977
Other noncurrent assets      
Other undisclosed noncurrent assets (1,312)1,0591,1361,144597357
Total noncurrent assets:11,11524,18553,45690,99285,54838,174
TOTAL ASSETS:64,21479,586151,198223,382174,399178,766
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,8029,9108,1059,30610,0582,393
Accounts payable1,8114,3254,6953,7636,1222,393
Accrued liabilities3,9915,5853,4105,5433,936 
Deferred revenue  296296296
Debt  3301,699  
Other liabilities204     
Deferred revenue and credits3,214
Due to related parties 4,59931,51527,400  
Other undisclosed current liabilities1,7731,8181,713 10,296 
Total current liabilities:7,77916,62341,95938,70120,3545,607
Noncurrent Liabilities
Long-term debt and lease obligation  7,5606,6886,251  
Long-term debt, excluding current maturities   1,428   
Liabilities, other than long-term debt10,0174,028   3,061
Deferred revenue and credits3,061
Due to related parties4,1633,828    
Other liabilities  200    
Operating lease, liability5,8547,5605,2606,251
Other undisclosed noncurrent liabilities19,657 (5,260) 20,000 
Total noncurrent liabilities:29,67411,5886,6886,25120,0003,061
Total liabilities:37,45328,21148,64744,95240,3548,668
Equity
Equity, attributable to parent26,76151,375102,551178,430134,045170,098
Common stock1771,472961836479469
Additional paid in capital722,049705,570672,304664,064543,754529,421
Accumulated other comprehensive loss(129)(27)(10)   
Accumulated deficit(695,336)(655,640)(570,704)(486,470)(410,188)(359,792)
Total equity:26,76151,375102,551178,430134,045170,098
TOTAL LIABILITIES AND EQUITY:64,21479,586151,198223,382174,399178,766

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,4143,00010,000 2,998837
Revenue, net837
Net investment income431     
Cost of revenue     (1,186)(661)
Gross profit:1,4143,00010,000 1,812176
Operating expenses(52,329)(92,836)(91,420)(77,090)(59,978)(28,012)
Operating loss:(50,915)(89,836)(81,420)(77,090)(58,166)(27,836)
Nonoperating income    1,506517
Investment income, nonoperating     1,506525
Interest and debt expense(736)(3,670)(4,115)(400)  
Loss from continuing operations:(51,651)(93,506)(85,535)(77,490)(56,660)(27,319)
Loss before gain (loss) on sale of properties:(93,506)(85,535)(77,490)(56,660)(27,319)
Net loss:(51,651)(93,506)(85,535)(77,490)(56,660)(27,319)
Other undisclosed net income (loss) attributable to parent11,9558,5701,3011,208(11) 
Net loss attributable to parent:(39,696)(84,936)(84,234)(76,282)(56,671)(27,319)
Preferred stock dividends and other adjustments (3,782)     
Net loss available to common stockholders, diluted:(43,478)(84,936)(84,234)(76,282)(56,671)(27,319)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(51,651)(93,506)(85,535)(77,490)(56,660)(27,319)
Other comprehensive income (loss)(102)(17)    
Comprehensive loss:(51,753)(93,523)(85,535)(77,490)(56,660)(27,319)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent8,1738,5701,291   
Comprehensive loss, net of tax, attributable to parent:(43,580)(84,953)(84,244)(77,490)(56,660)(27,319)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: